论文部分内容阅读
目的对采用肝素对紫癜性肾病进行防治的临床效果进行研究分析。方法抽取在过去一段时间内来我院就诊的72例患有过敏性紫癜的临床确诊患者的临床资料,将其分为A、B两组,每组36例。A组患者采用临床常规方法进行治疗,B组患者在常规治疗基础上采用低分子肝素进行治疗。结果 B组患者紫癜性肾病的发生率明显低于A组,紫癜性肾病的发生时间明显长于A组,B组皮疹消退时间明显短于A组。两组患者在治疗过程中均未出现比较严重的并发症和不良反应。结论采用肝素对紫癜性肾病进行防治的临床效果十分明显。
Objective To study the clinical effect of heparin on purpuric nephropathy. Methods The clinical data of 72 clinically diagnosed patients with Henoch-Schonlein Purpura from our hospital in the past period were collected and divided into groups A and B, with 36 cases in each group. Patients in group A were treated with routine clinical methods. Patients in group B were treated with LMWH on the basis of routine treatment. Results The incidence of purpura nephropathy in group B was significantly lower than that in group A, and the onset time of purpura nephropathy was significantly longer in group B than in group A, and the subsidence time in group B was significantly shorter than that in group A. Two groups of patients in the course of treatment did not appear more serious complications and adverse reactions. Conclusion The clinical effect of heparin on purpuric nephropathy is very obvious.